Muscimol-like discriminative stimulus effects of GABA agonists in rats

被引:14
|
作者
Jones, HE [1 ]
Balster, RL [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
drug discrimination; muscimol; GABA (gamma-aminobutyric acid); THIP; diazepam; GABA transaminase inhibitors; tiagabine; progabide; vigabatrin; valproic acid; rats;
D O I
10.1016/S0091-3057(97)00413-9
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The discriminative stimulus effects of GABAergic drugs were evaluated in rats trained to discriminate the direct GABA, agonist, muscimol (1.0 mg/kg IP), from saline under a two-lever fixed ratio (FR) 32 schedule of food reinforcement. Another direct GABA(A) agonist, THIP, produced full substitution for muscimol, however, at doses producing response rate decreasing effects. Diazepam, an allosteric modulator of GABA-mediated Postsynaptic inhibition, yielded a maximum of 50% muscimol-lever responding at a dose that also decreased rates of responding. Partial substitution for muscimol (maximal levels of 71% muscimol-lever responding) was also produced by the GABA agonist progabide. Propofol, an anesthetic that potentiates GABA(A) receptor function, and the GABA uptake inhibitor, tiagabine, produced no greater than 53 and 48% muscimol-lever responding, respectively. Valproic acid, a reversible GABA transaminase inhibitor, failed to substitute for muscimol, and vigabatrin, an irreversible GABA transaminase inhibitor, yielded a maximal 46% muscimol-lever responding. These results demonstrate the pharmacological specificity of muscimol discrimination by showing that only direct agonists for the GABA site on the GABA(A) receptor complex produce full substitution. GABA agonists acting by other mechanisms can be distinguished from muscimol and THIP in this procedure. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:319 / 326
页数:8
相关论文
共 50 条
  • [31] Characterization of the discriminative stimulus effects of lorcaserin in rats
    Serafine, Katherine M.
    Rice, Kenner C.
    France, Charles P.
    [J]. JOURNAL OF THE EXPERIMENTAL ANALYSIS OF BEHAVIOR, 2016, 106 (02) : 107 - 116
  • [32] Characterization of the discriminative stimulus effects of lorcaserin in rats
    Serafine, Katherine M.
    France, Charles P.
    [J]. FASEB JOURNAL, 2016, 30
  • [33] CENTRAL GABA RECEPTOR AGONISTS - COMPARISON OF MUSCIMOL AND BACLOFEN
    NAIK, SR
    GUIDOTTI, A
    COSTA, E
    [J]. NEUROPHARMACOLOGY, 1976, 15 (08) : 479 - 484
  • [34] Role of opioidergic mechanisms and GABA uptake inhibition in the heroin-induced discriminative stimulus effects in rats
    Solecki, W
    Krówka, T
    Filip, M
    Przewlocki, R
    [J]. PHARMACOLOGICAL REPORTS, 2005, 57 (06) : 744 - 754
  • [35] DISCRIMINATIVE STIMULUS PROPERTIES OF MUSCARINIC AGONISTS
    JUNG, M
    COSTA, L
    SHEARMAN, GT
    KELLY, PH
    [J]. PSYCHOPHARMACOLOGY, 1987, 93 (02) : 139 - 145
  • [36] Caffeine induces differential cross tolerance to the amphetamine-like discriminative stimulus effects of dopaminergic agonists
    Jain, R
    Holtzman, SG
    [J]. BRAIN RESEARCH BULLETIN, 2005, 65 (05) : 415 - 421
  • [37] Failure of ibogaine to produce phencyclidine-like discriminative stimulus effects in rats and monkeys
    Jones, HE
    Li, H
    Balster, RL
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 59 (02) : 413 - 418
  • [38] Characterization of the Discriminative Stimulus Effects of Binary Mixtures of Mu Opioid Receptor Agonists in Rats Discriminating Fentanyl
    Flynn, Shawn M.
    France, Charles P.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2022, 380 (03): : 171 - 179
  • [39] Discriminative Stimulus Effects of <it>Mu</it> Opioid Receptor Agonists in Rats Discriminating Fentanyl: Differential Antagonism by Naltrexone
    Flynn, Shawn
    France, Charles
    [J]. FASEB JOURNAL, 2020, 34
  • [40] μ-, δ- and κ-opioid receptor agonists do not alter the discriminative stimulus effects of cocaine or d-amphetamine in rats
    Woolfolk, DR
    Holtzman, SG
    [J]. DRUG AND ALCOHOL DEPENDENCE, 1997, 48 (03) : 209 - 220